UK Biobank analysis of 14,353 type 2 diabetes patients identified three distinct disease subtypes using routine clinical markers including BMI, blood pressure, and inflammatory proteins. The severe obesity-related inflammatory diabetes (SOID) subtype showed 24% higher dementia risk, 42% higher vascular dementia risk, and 48% higher ischemic stroke risk compared to mild metabolic diabetes. Most striking was the 88% increased cardiovascular mortality risk in the SOID group. Brain imaging in 779 participants revealed that SOID patients had measurably lower gray matter volume and greater white matter damage—structural changes consistent with accelerated brain aging. This data-driven approach moves beyond traditional one-size-fits-all diabetes management by revealing that inflammation and obesity create a particularly toxic neurological profile. The findings suggest clinicians could stratify diabetes patients for more intensive neuroprotective interventions based on readily available lab values and BMI. However, this preprint awaits peer review, and the observational design cannot establish causation. While confirmatory of existing obesity-inflammation research, the precise quantification of neurological risks across diabetes subtypes offers actionable clinical intelligence for personalized prevention strategies.